We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNUC
12626
CALL
Frontier Nuclear and Minerals Inc
FNUC
$47.9M
$17.6K ﹤0.01%
1,038
-370
-26% -$9.18K
WRAP icon
12627
CALL
Wrap Technologies
WRAP
$105M
$17.6K ﹤0.01%
11,700
-1,200
-9% -$2.02K
CSTE icon
12628
PUT
Caesarstone
CSTE
$119M
$17.5K ﹤0.01%
4,100
-5,100
-55% -$24.6K
SXT icon
12629
PUT
Sensient Technologies
SXT
$5.68B
$17.5K ﹤0.01%
+300
New +$18.9K
ADMA icon
12630
CALL
ADMA Biologics
ADMA
$2.12B
$17.5K ﹤0.01%
4,900
-6,700
-58% -$25.8K
BRLT icon
12631
Brilliant Earth
BRLT
$22.5M
$17.5K ﹤0.01%
5,935
+3,697
+165% +$13.3K
BCDA icon
12632
CALL
BioCardia
BCDA
$14.7M
$17.5K ﹤0.01%
2,727
+994
+57% +$16.7K
KBWY icon
12633
PUT
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$309M
$17.5K ﹤0.01%
1,000
-2,900
-74% -$54.4K
KOD icon
12634
PUT
Kodiak Sciences
KOD
$2.6B
$17.5K ﹤0.01%
9,700
-109,200
-92% -$385K
GBIO
12635
PUT
DELISTED
Generation Bio
GBIO
$17.4K ﹤0.01%
460
-80
-15% -$3.79K
KLRS
12636
CALL
Kalaris Therapeutics
KLRS
$97.1M
$17.4K ﹤0.01%
352
-439
-55% -$29.9K
UP icon
12637
PUT
Wheels Up
UP
$182M
$17.4K ﹤0.01%
420
-25
-6% -$1.01K
OMAB icon
12638
CALL
Grupo Aeroportuario Centro Norte
OMAB
$4.99B
$17.4K ﹤0.01%
200
-100
-33% -$9.04K
LRMR icon
12639
CALL
Larimar Therapeutics
LRMR
$453M
$17.4K ﹤0.01%
4,400
+2,200
+100% +$8.32K
NFE icon
12640
New Fortress Energy
NFE
$92.6M
$17.4K ﹤0.01%
530
-167,939
-100% -$4.94M
KCE icon
12641
PUT
State Street SPDR S&P Capital Markets ETF
KCE
$480M
$17.4K ﹤0.01%
200
-3,500
-95% -$311K
TMC icon
12642
PUT
TMC The Metals Company
TMC
$1.77B
$17.3K ﹤0.01%
17,500
-12,100
-41% -$17.4K
STOK icon
12643
PUT
Stoke Therapeutics
STOK
$2.02B
$17.3K ﹤0.01%
4,400
-8,200
-65% -$53.9K
DMTK
12644
DELISTED
DermTech, Inc. Common Stock
DMTK
$17.3K ﹤0.01%
11,991
+9,927
+481% +$24.8K
DSGN icon
12645
CALL
Design Therapeutics
DSGN
$928M
$17.2K ﹤0.01%
7,300
+6,100
+508% +$28.5K
CLSD
12646
DELISTED
Clearside Biomedical
CLSD
$17.2K ﹤0.01%
1,317
+160
+14% +$2.42K
TDCX
12647
PUT
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$17.1K ﹤0.01%
2,900
+600
+26% +$3.94K
NEXR
12648
Nexera Technologies Ltd
NEXR
$1.59M
0
HYPD
12649
PUT
Hyperion DeFi Inc
HYPD
$41.2M
$17.1K ﹤0.01%
129
-69
-35% -$11.1K
WSBC icon
12650
PUT
WesBanco
WSBC
$4.09B
$17.1K ﹤0.01%
700
-1,100
-61% -$28.6K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.